Shelly Herrington, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 801 S State St, Bassett, NE 68714 Phone: 402-684-2906 Fax: 402-684-3822 |
Crystal Gayle Dailey, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 801 S State St, Bassett, NE 68714 Phone: 402-684-2906 Fax: 402-684-3822 |
Brittany Devall Heyden, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 202 E Highway 20, Bassett, NE 68714 Phone: 402-302-0090 Fax: 833-939-0197 |
Catherine Sue Sybrant, APRN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 801 S State St, Bassett, NE 68714 Phone: 402-684-2906 Fax: 402-684-3822 |
Murlene Nollmeyer Osburn, APRN Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 202 E Highway 20, Bassett, NE 68714 Phone: 402-382-0911 Fax: 402-913-3454 |
Tara L Swanson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 E South Street, Bassett, NE 68714 Phone: 402-684-2285 Fax: 402-684-2299 |
Abbie Marie Albrecht, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 801 S State St, Bassett, NE 68714 Phone: 402-684-2906 Fax: 402-684-3822 |
News Archive
Nitric oxide supplementation using a Neo40 lozenge significantly helps promote normal blood pressure, as indicated by a 30-day, blinded, placebo-controlled clinical study, conducted at the California Medical Institute by renowned cardiology researcher Dr. Ernst Schwarz.
The surge of funds for bioterrorism preparedness over the past decade does not appear to be improving local public health resources in general, according to research from Purdue University.
Scientists from two universities in Italy and Virginia Tech in the United States have determined the structure of a protein that is responsible for the production xanthurenic acid (XA) in Anopheles gambiae, the malaria carrying mosquitoes.
Researchers in the Netherlands, the United States, and Belgium have presented early-stage clinical trial results demonstrating the safety and efficacy of Johnson & Johnson's vaccine candidate for coronavirus disease 2019 (COVID-19).
› Verified 8 days ago